缩写名/全名 |
ANTICANCER RES
ANTICANCER RESEARCH |
||||||||||||||||||||
ISSN号 | 0250-7005 | ||||||||||||||||||||
研究方向 | 医学-肿瘤学 | ||||||||||||||||||||
影响因子 | 2015:1.895, 2016:1.937, 2017:1.865, 2018:1.935, 2019:1.994, | ||||||||||||||||||||
出版国家 | GREECE | ||||||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||||||
年文章数 | 763 | ||||||||||||||||||||
出版年份 | 1981 | ||||||||||||||||||||
是否OA | No | ||||||||||||||||||||
审稿周期(仅供参考) | 平均2月 |
||||||||||||||||||||
录用比例 | 约35% | ||||||||||||||||||||
投稿链接 | http://www.iiar-submissions.com/login.html | ||||||||||||||||||||
投稿官网 | http://ar.iiarjournals.org/ | ||||||||||||||||||||
h-index | 110 | ||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0250-7005%5BISSN%5D | ||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | Etomidate Suppresses Invasion and Migration of Human A549 Lung Adenocarcinoma Cells. Author: Chu CN1,2, Wu KC3,4, Chung WS5, Zheng LC6, Juan TK6, Hsiao YT6, Peng SF6, Yang JL6, Ma YS7,8, Wu RS9,10, Chung JG11,12. Journal: Anticancer Res. 2019 Jan;39(1):215-223. doi: 10.21873/anticanres.13100. PubMed DOI |
2. | Cell-penetrating Peptide-coated Liposomes for Drug Delivery Across the Blood-Brain Barrier. Author: Yuan BO1, Zhao Y2, Dong S2, Sun Y2, Hao F2, Xie J2, Teng L2, Lee RJ3,4, Fu Y5, Bi YE3,6. Journal: Anticancer Res. 2019 Jan;39(1):237-243. doi: 10.21873/anticanres.13103. PubMed DOI |
3. | Outcomes of Localized Esophageal Squamous Cell Carcinoma Patients Treated With Definitive Concurrent Chemoradiotherapy Using Either Standard or High Radiotherapy Dose: A Retrospective Study Controlling for Organ at Risk Dose. Author: Li CC1, Fang HY2,3, Lin CY4, Shen WC5, Chien CR6,3,7. Journal: Anticancer Res. 2019 Jan;39(1):511-517. doi: 10.21873/anticanres.13142. PubMed DOI |
4. | The C-Terminus of Hepatitis B Virus-encoded X Protein Is Required for Lapatinib Sensitivity in Hepatocellular Carcinoma Cells. Author: Chen JY1,2, Huang WC1,2,3,4,5,6, Wei CT7,8, Chien PH9, Chen YJ10,9,11. Journal: Anticancer Res. 2019 Feb;39(2):721-726. doi: 10.21873/anticanres.13168. PubMed DOI |
5. | County Median Family Income Is an Independent Prognostic Factor for Stage IV Anaplastic Thyroid Cancer. Author: Li MU1, Gu S2, Mao R3, Ning Y1, Trivedi N4, Siddiqui A5, Li P1, Huo L6. Journal: Anticancer Res. 2019 Feb;39(2):949-956. doi: 10.21873/anticanres.13198. PubMed DOI |
6. | GastroPanel® Biomarker Assay: The Most Comprehensive Test for Helicobacter pylori Infection and Its Clinical Sequelae. A Critical Review. Author: Syrjänen K1,2, Eskelinen M3, Peetsalu A4, Sillakivi T4, Sipponen P5, Härkönen M6, Paloheimo L7, Mäki M7, Tiusanen T7, Suovaniemi O6,7, DiMARIO F8, Fan ZP9. Journal: Anticancer Res. 2019 Mar;39(3):1091-1104. doi: 10.21873/anticanres.13218. PubMed DOI |
7. | β-Catenin Expression Correlates With Prognosis in Hepatocellular Carcinoma Patients Treated With Transcatheter Arterial Chemoembolization. Author: Xu X1,2, Gao D2, Yuan X3, Liu LI2, Zhang X1, Liang X1, Chen S1,2, Ai M2, Chen BO2, Shi D2, Yang Z4, Hoffman RM4, Xu J5,2. Journal: Anticancer Res. 2019 Mar;39(3):1129-1134. doi: 10.21873/anticanres.13221. PubMed DOI |
8. | Targeted and Efficient Delivery of siRNA Using Tunable Polymeric Hybrid Micelles for Tumor Therapy. Author: Hao F1, Dong S1, Yang C1, Li Z1, Cheng Z1, Zhong L1, Teng L1, Meng Q1, Lu J1, Wu F2, Xie J3, Teng L3, Lee RJ3,4. Journal: Anticancer Res. 2019 Mar;39(3):1169-1178. doi: 10.21873/anticanres.13226. PubMed DOI |
9. | Association of Matrix Metallopeptidase-2 Promoter Polymorphisms With the Risk of Childhood Leukemia. Author: Hsu PC1, Pei JS1, Chen CC1, Chang WS2, Kuo CC3, Cheng SP4, Tsai CW5, Bau DT5,6,7, Gong CL8. Journal: Anticancer Res. 2019 Mar;39(3):1185-1190. doi: 10.21873/anticanres.13228. PubMed DOI |
10. | Prognostic Factors in Early-stage NSCLC: Analysis of the Placebo Group in the MAGRIT Study. Author: Cho BC1, DE Pas T2, Kalofonos H3, Wang Q4, Ramlau R5, Cheng Y6, Vitiello F7, Laisaar T8, Vallières E9, Kubisa B10, Orlov S11, Park K12, Debruyne C13, Vansteenkiste J14. Journal: Anticancer Res. 2019 Mar;39(3):1403-1409. doi: 10.21873/anticanres.13255. PubMed DOI |
|
|